Highlights from this issue
Pneumonia classification and healthcare-associated pneumonia
Xpert MTB/RIF and pulmonary tuberculosis
Cytisine and the failure to market and regulate for human health
The role of vitamin D supplementation in the risk of developing pneumonia
Fluticasone/salmeterol is associated with a higher risk of pneumonia and pneumonia related events in comparison with budesonide/formoterol in patients with COPD
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia
Community-acquired pneumonia in Chile
Microbial aetiology of healthcare associated pneumonia in Spain
The five-repetition sit-to-stand test as a functional outcome measure in COPD
Combined effects of parental and active smoking on early lung function deficits
Inhaled corticosteroids in COPD and the risk of serious pneumonia
Efficacy of cytisine in helping smokers quit
Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid
Pneumonia in low and middle income countries
Risk factors for community-acquired pneumonia in adults in Europe
Economic evaluation of a pneumococcal vaccine in a high-risk population
Limited generalisability of UPLIFT findings to clinical practice
An initiative offering free pneumococcal vaccination to victims of the Great East Japan earthquake
Single versus combination antibiotic therapy in adults hospitalised with community-acquired pneumonia
Authors’ response
The number needed to treat provides additional insight on the performance of detection points of asthma exacerbations in self-management plans
Significance of halo, reversed halo and air crescent signs in lymphomatoid granulomatosis and pulmonary fungal infections
The number needed to treat provides additional insight on the performance of detection points of asthma exacerbations in self-management plans
Low concordance with HIV testing guidelines in a retrospective review of intensive care practice
A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis
Cavitating pulmonary nodules growing in a favourable medium
Tuberculosis during TNF-α inhibitor therapy, despite screening
Leonardo da Vinci and the first portrayal of pectus excavatum
November Journal club summaries